Back to search

Belgium· BE-AMP-SAM660812-00

Teriflunomide EG 14 mg

A teriflunomide product containing teriflunomide, registered in Belgium by EG. The same ATC class is registered in 14 of our 19 countries.

ATC L04AK02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTeriflunomide EG 14 mgATCL04AK02REGISTER NO.BE-AMP-SAM660812-00PACKS LISTED3CHECKEDSeptember 26, 2026

Where it is registered

Teriflunomide is registered in 14 of 19 countries.

Countries holding a registration under ATC L04AK02 (teriflunomide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Teriflunomide · ATC L04AK02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of teriflunomide costs, country by country.

Normalised to the WHO defined daily dose (14 mg), the median price runs from $18.33 in Switzerland to $28.01 in Italy — a ×1.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Teriflunomide · price per daily dose (14 mg)

USD · FX 28 Sept 2026

  • IT Italy$28.01
  • CH Switzerland$18.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Teriflunomide
Manufacturer
EG
Country
Belgium (BE)
ATC code
L04AK02
ATC class
Teriflunomide
Defined daily dose
14 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

2 priced
  • be_apb
    4751848
    EUR 313.04
  • be_apb
    4751855
    EUR 722.32
  • be_apb
    7738727

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

668 interactions on record for teriflunomide.

Graded by severity as the source publishes them — 542 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Teriflunomide · interactions on record

668 records

  • 542 severe
  • 116 moderate
  • 10 minor

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • Chenodeoxycholic acidA05AA01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Teriflunomide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teriflunomide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Terebyo, Teriflunomid +pharma
  • Bulgaria · Terebyo, Teriflunomide Msn
  • Cyprus · Aregalu, Arogio
  • Czechia · Aregalu, Boxarid
  • Germany · Terebyo, Teriflago
  • Denmark · Clefirem, Teriflunomid Devatis
  • Estonia · Aregalu, Boxarid
  • Spain · Clefirem, Teriflunomida Aurovitas
  • Finland · Clefirem, Teriflunomide Avansor
  • France · Terebyo, Teriflunomide Arrow
  • United Kingdom (Northern Ireland) · Teriflunomide, Teriflunomide Abdi
  • Greece · Aregalu, Arogio
  • Croatia · Aregalu, Telirem
  • Hungary · Aregalu, Arogio
  • Ireland · Teriflunomide Clonmel
  • Iceland · Aubagio, Feple
  • Italy · Clefirem, Terebyo
  • Liechtenstein · Aubagio, Teriflunomide Accord
  • Lithuania · Aregalu, Boxarid
  • Luxembourg · Teriflunomide Eg, Teriflunomide Eg (Eurogenerics)
  • Latvia · Aregalu, Boxarid
  • Malta · Telirem, Tergio
  • Netherlands · Teriflox, Teriflunomide Abdi
  • Norway · Aubagio, Clefirem
  • Poland · Aregalu, Boxarid
  • Portugal · Teriflunomida Basi, Teriflunomida Bluepharma
  • Romania · Aregalu, Boxarid
  • Sweden · Clefirem, Teriflunomid Devatis
  • Slovenia · Aregalu, Clefirem
  • Slovakia · Aregalu, Boxarid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce0e9c04-a7d9-41f3-987a-0a7eced3aaf2
GET /v1/drugs/ce0e9c04-a7d9-41f3-987a-0a7eced3aaf2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Teriflunomide EG 14 mg",
  "name_fr": "Teriflunomide EG 14 mg",
  "name_nl": "Teriflunomide EG 14 mg",
  "amp_code": "SAM660812-00",
  "strengths": [
    "14.0000",
    "47.5000",
    "15.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Teriflunomide",
    "Lactose Monohydrate",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Teriflunomide",
  "authorisation_numbers": [
    "BE660812"
  ]
}

See everything about teriflunomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.